Ali Ataya, MD : Research

The purpose of this study is to: evaluate the safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) of single ascending doses of ALN-6400 in healthy volunteers evaluate the efficacy, safety, tolerability and PD of multiple doses of…

Investigator

Ali Ataya

Status

Accepting Candidates

Ages

18 Years - N/A

Sexes

All

Investigator

Ali Ataya

Status

Accepting Candidates

This open-label extension study will evaluate the long-term safety, tolerability and efficacy of orally inhaled seralutinib in subjects who have completed a previous seralutinib study

Investigator

Ali Ataya

Status

Accepting Candidates

Ages

18 Years - 75 Years

Sexes

All